Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients

BACKGROUND: COVID-19 pandemic continues, clarifying signatures in clinical characters and antibody responses between severe and non-severe COVID-19 cases would benefit the prognosis and treatment. METHODS: In this study, 119 serum samples from 37 severe or non-severe COVID-19 patients from the First...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongye, Yan, Dongshan, Li, Ya, Gong, Yanfei, Mai, Yulin, Li, Bingxiang, Zhu, Xiaoyong, Wan, Xinrui, Xie, Liyun, Jiang, HuaKe, Zhang, Min, Sun, Ming, Yao, Yufeng, Zhu, Yongzhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809634/
https://www.ncbi.nlm.nih.gov/pubmed/35109926
http://dx.doi.org/10.1186/s40249-022-00940-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809634/
https://www.ncbi.nlm.nih.gov/pubmed/35109926
http://dx.doi.org/10.1186/s40249-022-00940-w

Ejemplares similares